Cannabinoid CB1 receptor antagonists reduce bodyweight in rodents and human beings, but their medical utility as anti-obesity agents is bound by centrally mediated unwanted effects. Benzoylaconitine 1B). The decrease in food intake had not been apt to be caused by nonspecific behavioral results, as URB447 (20 mg-kg?1, i.p.) didn’t alter engine activity (data not really… Continue reading Cannabinoid CB1 receptor antagonists reduce bodyweight in rodents and human beings,